JPS6234396B2 - - Google Patents

Info

Publication number
JPS6234396B2
JPS6234396B2 JP56189857A JP18985781A JPS6234396B2 JP S6234396 B2 JPS6234396 B2 JP S6234396B2 JP 56189857 A JP56189857 A JP 56189857A JP 18985781 A JP18985781 A JP 18985781A JP S6234396 B2 JPS6234396 B2 JP S6234396B2
Authority
JP
Japan
Prior art keywords
inhibitor
inhibitors
starch
amylase
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56189857A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57150396A (en
Inventor
Furomaa Uerunaa
Purusu Warutaa
Sheefuaa Deiitomaa
Shumitsuto Terufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS57150396A publication Critical patent/JPS57150396A/ja
Publication of JPS6234396B2 publication Critical patent/JPS6234396B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP56189857A 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme Granted JPS57150396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (2)

Publication Number Publication Date
JPS57150396A JPS57150396A (en) 1982-09-17
JPS6234396B2 true JPS6234396B2 (enrdf_load_stackoverflow) 1987-07-27

Family

ID=5792372

Family Applications (3)

Application Number Title Priority Date Filing Date
JP10558571A Pending JPS5734996B1 (enrdf_load_stackoverflow) 1970-12-28 1971-12-27
JP56189856A Granted JPS57150395A (en) 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme
JP56189857A Granted JPS57150396A (en) 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP10558571A Pending JPS5734996B1 (enrdf_load_stackoverflow) 1970-12-28 1971-12-27
JP56189856A Granted JPS57150395A (en) 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme

Country Status (28)

Country Link
US (1) US3876766A (enrdf_load_stackoverflow)
JP (3) JPS5734996B1 (enrdf_load_stackoverflow)
KR (1) KR780000248B1 (enrdf_load_stackoverflow)
AR (1) AR193370A1 (enrdf_load_stackoverflow)
AT (1) AT330122B (enrdf_load_stackoverflow)
AU (1) AU461521B2 (enrdf_load_stackoverflow)
BE (1) BE777387A (enrdf_load_stackoverflow)
BG (3) BG25654A3 (enrdf_load_stackoverflow)
CA (1) CA979833A (enrdf_load_stackoverflow)
CH (1) CH594051A5 (enrdf_load_stackoverflow)
CS (1) CS167961B2 (enrdf_load_stackoverflow)
DD (1) DD99395A5 (enrdf_load_stackoverflow)
DE (1) DE2064092C2 (enrdf_load_stackoverflow)
DK (1) DK139533C (enrdf_load_stackoverflow)
ES (1) ES398358A1 (enrdf_load_stackoverflow)
FI (1) FI49774C (enrdf_load_stackoverflow)
FR (1) FR2120073B1 (enrdf_load_stackoverflow)
GB (1) GB1374751A (enrdf_load_stackoverflow)
IE (1) IE35920B1 (enrdf_load_stackoverflow)
IL (1) IL38441A (enrdf_load_stackoverflow)
LU (1) LU64319A1 (enrdf_load_stackoverflow)
NL (1) NL175199C (enrdf_load_stackoverflow)
NO (1) NO135873C (enrdf_load_stackoverflow)
PL (1) PL82900B1 (enrdf_load_stackoverflow)
RO (3) RO63065A (enrdf_load_stackoverflow)
SE (1) SE398357B (enrdf_load_stackoverflow)
SU (1) SU454750A3 (enrdf_load_stackoverflow)
ZA (1) ZA718677B (enrdf_load_stackoverflow)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
ATE89563T1 (de) * 1986-08-13 1993-06-15 Hoechst Ag Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
JP3992497B2 (ja) 1999-10-28 2007-10-17 チョン・クン・ダン・ファーマシューティカル・コーポレーション 高純度アカルボース製造方法
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
CN104144942A (zh) 2011-12-08 2014-11-12 拜耳知识产权有限责任公司 来自游动放线菌属菌种se50/110的新的放射菌整合和接合元件作为用于相关放线菌基因转化的质粒
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
EP4045520A1 (en) 2019-10-16 2022-08-24 Bayer Aktiengesellschaft Methods for the improved formation of acarbose
WO2021195087A1 (en) 2020-03-23 2021-09-30 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
DK139533B (da) 1979-03-05
ATA1111571A (de) 1975-09-15
DK139533C (da) 1979-08-20
IL38441A (en) 1974-10-22
NO135873C (enrdf_load_stackoverflow) 1977-06-15
JPS6216638B2 (enrdf_load_stackoverflow) 1987-04-14
CH594051A5 (enrdf_load_stackoverflow) 1977-12-30
IL38441A0 (en) 1972-02-29
FR2120073B1 (enrdf_load_stackoverflow) 1975-12-26
NL175199B (nl) 1984-05-01
JPS57150395A (en) 1982-09-17
LU64319A1 (enrdf_load_stackoverflow) 1972-06-13
AR193370A1 (es) 1973-04-23
PL82900B1 (enrdf_load_stackoverflow) 1975-10-31
ZA718677B (en) 1972-09-27
FI49774B (enrdf_load_stackoverflow) 1975-06-30
CA979833A (en) 1975-12-16
NL175199C (nl) 1984-10-01
US3876766A (en) 1975-04-08
DD99395A5 (enrdf_load_stackoverflow) 1973-08-05
SE398357B (sv) 1977-12-19
SU454750A3 (ru) 1974-12-25
FI49774C (fi) 1975-10-10
ES398358A1 (es) 1974-09-01
CS167961B2 (enrdf_load_stackoverflow) 1976-05-28
RO63064A (fr) 1978-06-15
JPS5734996B1 (enrdf_load_stackoverflow) 1982-07-26
GB1374751A (en) 1974-11-20
NO135873B (enrdf_load_stackoverflow) 1977-03-07
NL7117893A (enrdf_load_stackoverflow) 1972-06-30
IE35920L (en) 1972-06-28
FR2120073A1 (enrdf_load_stackoverflow) 1972-08-11
AT330122B (de) 1976-06-10
BG26002A4 (bg) 1979-01-12
AU3721471A (en) 1973-09-27
RO61400A (enrdf_load_stackoverflow) 1977-01-15
BG26003A4 (bg) 1979-01-12
BG25654A3 (bg) 1978-11-10
RO63065A (fr) 1979-02-15
AU461521B2 (en) 1975-05-29
BE777387A (fr) 1972-06-28
DE2064092C2 (de) 1983-06-01
IE35920B1 (en) 1976-06-23
JPS57150396A (en) 1982-09-17
DE2064092A1 (de) 1972-07-20
KR780000248B1 (en) 1978-07-06

Similar Documents

Publication Publication Date Title
JPS6234396B2 (enrdf_load_stackoverflow)
KR101925096B1 (ko) 숙취해소효소 분말의 제조방법 및 이를 포함하는 숙취해소용 조성물
NO813407L (no) Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse
JPS643877B2 (enrdf_load_stackoverflow)
US11976098B2 (en) Cooked millet prolamin peptide for inhibiting alpha-amylase and alpha-glucosidase
US4010258A (en) Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4019960A (en) Process for the production of a saccharase inhibitor
KR0177832B1 (ko) 감초 추출물을 사용한 조성물
US4282318A (en) α-Amylase inhibitor from a streptomycete and process for its preparation
JP4309108B2 (ja) 糖尿病治療薬
US3937817A (en) Pharmaceutical compositions containing a saccharase inhibitor
JP2003210136A (ja) 保健栄養食品の製造方法
US4271067A (en) Glycopeptide
PL91664B1 (enrdf_load_stackoverflow)
NO853461L (no) Nye alfa-glukosidaseinhibitor, fremgangsmaate til dens fremstilling, dens anvendelse og farmasoeytiske preparater.
US4013510A (en) Glycoside-hydrolase enzyme inhibitors
US3879546A (en) Saccharase inhibitors
US3934006A (en) Pharmaceutical compositions comprising saccharase inhibitors
JPS61134398A (ja) 新生理活性物質プリパスタチン及びその製造法
US3995026A (en) Amylase inhibitor
US3951745A (en) Glycoside-hydrolase enzyme inhibitors
JP2021143132A (ja) アンジオテンシンｉ変換酵素阻害用組成物
JPH10245341A (ja) 血糖降下組成物
KR20200016610A (ko) 지방간 개선제 조성물
JPH06116156A (ja) 血糖値低下剤